Submitted by Anonymous (not verified) on 18 February 2026 - 10:30
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Date of authorisation: 25/08/2025, Revision: 2, Status: Authorised
Source: